Introduction
============

Recent data indicate that bone marrow plays an important role not only as a primary lymphoid organ responsible for haemopoiesis, but also as a secondary lymphoid organ with capability of antigen presentation exceeding that of lymph nodes. Although in chronic inflammatory/immune disease, like rheumatoid arthritis (RA), bone marrow participates in the initiation and/or perpetuation of the disease, there is little information about the real number of lymphocyte subpopulations in bone marrow of these patients and how they can be modulated by T-cell growth factors. IL-15 acting through IL-15 receptors (including the high-affinity IL-15R alpha chain) is a key cytokine influencing the development of natural killer cells in bone marrow, and proliferation and maintenance of the memory T-cell pool. However, there is no information about the levels of IL-15 in bone marrow.

Objective
=========

In the present study we measured the real numbers of lymphocyte subsets in bone marrow isolated from RA and osteoarthritis (OA) patients in correlation with the levels of soluble IL-15 and surface-expressed IL-15R alpha.

Methods
=======

Bone marrow samples, obtained from nine RA and nine OA patients (mean age 53.1 ± 10.6 years and 54.3 ± 13.6 years, respectively) undergoing joint replacement surgery, were diluted four times in heparinized PBS. Bone marrow plasma samples were obtained by centrifugation and levels of IL-15 were measured using specific ELISA. The real number of lymphocytes stained for CD3^+^, CD4^+^, CD8^+^and CD19^+^were counted in the presence of TruCount beads using flow cytometry. Surface-expressed IL-15R was done on cells separated by gradient centrifugation, acid wash of surface-bound IL-15 and flow cytometric analysis.

Results
=======

The real number of CD3^+^, CD4^+^, CD8^+^T cells and CD19^+^B cells, and statistical significance of these data are presented in Table [1](#T1){ref-type="table"}. There were twice as many T (CD3^+^) cells in RA in comparison with OA bone marrow. In contrast, only 42% of B (CD19^+^) cells present in OA were observed in RA. Interestingly, lymphocytes isolated from RA patients expressed a significantly higher level of surface IL-15R alpha chain, indicating their activation status. In addition, there is a tendency (although not statistically significant, *P*= 0.08) for elevated levels of IL-15 in bone marrow plasma from RA in comparison with OA patients (2390 ± 1687 pg/ml and 1292 ± 457 pg/ml, respectively).

###### 

Real number of lymphocytes isolated from bone marrow of rheumatoid arthritis (RA) and osteoarthritis (OA) patients

  Patients       CD3^+^        CD4^+^        CD8^+^       CD19^+^
  -------------- ------------- ------------- ------------ ------------
  RA             6.1 ± 2.8     3.0 ± 1.2     3.0 ± 1.7    0.85 ± 0.3
  OA             3.2 ± 1.6     1.6 ± 0.8     1.6 ± 0.9    2.0 ± 0.9
  RA versus OA   *P*\< 0.008   *P*\< 0.004   *P*\< 0.03   *P*\< 0.02

Data presented as cell number × 10^6^/ml bone marrow.

Conclusion
==========

A highly significant increase of CD3^+^(both CD4^+^and CD8^+^) T-cell numbers in RA in comparison with OA suggest that T cells in RA are actively trafficking to bone marrow or vigorously proliferate *in situ*, or both. Since lymphocytes from RA, in contrast to OA, express IL-15 receptors, and since there is a tendency to higher levels of IL-15 in RA, it is likely that T cells actively proliferate in bone marrow in response to locally produced IL-15. Significantly lower B-cell numbers in RA than in OA suggest that these cells actively emigrate from RA bone marrow to peripheral blood and affected joints.
